Triple- and Multi-echo MRI and MRS medians for no steatosis, mild, moderate, and severe steatosis using biopsy evaluations as reference values.

<p>MRI, magnetic resonance imaging; MRS, magnetic resonance spectroscopy; IQR, interquartile range;</p><p>All the groups were compared by 2×2 independent sample tests and the p values were <0.05 in all the analyses.</p><p>Triple- and Multi-echo MRI and MRS medians for no steatosis, mild, moderate, and severe steatosis using biopsy evaluations as reference values.</p

Diagnostic performance for triple- and multi-echo sequences, and MRS using histopathology as the gold standard.

<p>The best cut-off point was identified using the Youden index.</p

Univariable linear regressions analyses for each one of the imaging techniques.

<p>S.E., standard error; ROC, receiver operating characteristic; AUC, area under the curve; MRS, magnetic resonance spectroscopy.</p><p>Univariable linear regressions analyses for each one of the imaging techniques.</p

Correlations between triple- and multi-echo sequences and MR spectroscopy versus histopathology examination.

<p>Correlations between triple- and multi-echo sequences and MR spectroscopy versus histopathology examination.</p

Triple- and Multi-echo Sequences Parameters.

<p>TR, repetition time; FOV, field of view; NSA, number of signals averaged; SENSE, sensitivity encoding.</p><p>Triple- and Multi-echo Sequences Parameters.</p

Representative out-of-phase MR images from a 62 year-old woman with type 2 diabetes and moderate steatosis.

<p>MR images obtained from breath-hold T1-weighted triple-echo spoiled gradient-echo sequence. ROI was manually drawn at the spectroscopic voxel location (segment V, colocalized with liver biopsy), as shown. ROI, region of interest.</p